04:19 EDT 26th August 2019 | BioPortfolio

Nexium is the 2nd most profitable drug in 2009, according to 2009 annual sales figures, where it generated just over $5m in sales for its company, AstraZeneca Pharmaceuticals. 

Nexium is a proton pump inhibitor, acting to reduce the amount of acid produced by the stomach. Reducing the acid production reduces the symptoms and the risks of some diseases including gastric ulcers, GERD and Zollinger-Ellison syndrome.

What is NEXIUM?

NEXIUM is a prescription medicine called a proton pump inhibitor (PPI). NEXIUM reduces the amount of acid in your
NEXIUM is used in adults: 

•  for 4 to 8 weeks to treat the symptoms of gastroesophageal reflux disease (GERD). NEXIUM may also be prescribed to heal acid-related damage to the lining of the esophagus (erosive esophagitis), and to help continue this healing. GERD happens when acid in your stomach backs up into the tube (esophagus) that connects your mouth to your stomach. This may cause a burning feeling in your chest or throat, sour taste, or burping.
•  for up to 6 months to reduce the risk of stomach ulcers in some people taking pain medicines called non-steroidal anti-inflammatory drugs (NSAIDs).
•  to treat patients with a stomach infection (Helicobacter pylori), along with the antibiotics amoxicillin and clarithromycin.

•  for the long-term treatment of conditions where your stomach makes too much acid, including ZollingerEllison Syndrome. Zollinger-Ellison Syndrome is a rare condition in which the stomach produces a more than normal amount of acid.

Source; BioPortfolio and

Follow the Nexium Twitter feed;

Quick Search

review and buy Nexium market research data and corporate reports here